0
The enzyme SETDB2 is implicated in the development of runaway inflammation characteristic of severe COVID-19 in patients with diabetes who are infected with coronavirus.
The enzyme SETDB2 is implicated in the development of runaway inflammation characteristic of severe COVID-19 in patients with diabetes who are infected with coronavirus.